معرفی
Paul Davies is a Research Professor in Neuroscience at the Tufts University School of Medicine. His research focuses on the physiology and pharmacology of Cys-loop ligand-gated ion channels (LGICs), particularly their roles in neuropsychiatric disorders like epilepsy, anxiety, and schizophrenia. He uses patch-clamp techniques to study ion channel function in LGICs. Davies holds a BSc and PhD from the University of Dundee.
Research Interests:
- Ion channel pharmacology and physiology
- Mechanisms of GABAergic inhibition
- Neurosteroid actions on GABAA receptors
- Zinc-activated channel (ZAC) biology
- Neurodevelopmental disorders (e.g., Fragile X syndrome)
Key Contributions:
His work includes groundbreaking studies on KCC2 function in neural excitability, neuroactive steroids' therapeutic potential, and the discovery of ZAC antagonists. Recent articles (2021–2025) highlight advancements in understanding KCC2's role in neuron survival, ZAC variant effects, and novel treatments for seizure disorders.
Grants & Funding:
- National Institutes of Health grants (2015–present) for research on neurosteroids, KCC2 mutations, and tonic inhibition deficits
- Industry partnerships, including Ovid Therapeutics collaborations
Professional Activities:
Davies serves on the IUPHAR NC nomenclature committee for ZAC channels and reviews for journals like Journal of Neuroscience and Neuropharmacology. He has presented at conferences such as Experimental Biology and the International Conference on Anesthesia.
